
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair. - 2
Pick Your Favored kind of salad - 3
He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com. - 4
Magnetic fossils may reveal ancient creature's internal 'GPS system' - 5
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
Italian court approves extradition to Germany of Ukrainian suspect in Nord Stream pipeline blast
Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?
Don't fall for it: These common tourist scams in Rome are easy to avoid if you know what you're looking for
Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'
Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
Humpback whale freed by rescuers in Baltic Sea has become stranded again
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push













